GTCR, Surmodics say US FTC market definition 'fails to reflect commercial realities'
MLex Summary: Biotech firms GTCR and Surmodics — two rival medical device coating creators — claim the relevant antitrust market that the US Federal Trade Commission, Minnesota and Illinois relied upon when challenging...To view the full article, register now.
Already a subscriber? Click here to view full article